Characterization of the promoter for the mouse a3 integrin geneInvolvement of the Ets-family of transcription factors in the promoter activity Takumi Kato1, Kouji Katabami1, Hironori Tak
Trang 1Characterization of the promoter for the mouse a3 integrin gene
Involvement of the Ets-family of transcription factors in the promoter activity
Takumi Kato1, Kouji Katabami1, Hironori Takatsuki1, Seon Ae Han2, Ken-ichi Takeuchi2, Tatsuro Irimura2 and Tsutomu Tsuji1,2
1
Department of Microbiology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan;2Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan
The a3b1 integrin is an adhesion receptor for extracellular
matrix proteins including isoforms of laminin, and the
changes of its expression level in various cancer cells are
thought to cause their malignant phenotypes We have
cloned an approximately 4 kb DNA fragment of the
5¢-flanking region of the murine a3 integrin gene and analyzed
its promoter activity Transfection of MKN1 gastric
carci-noma cells with serially truncated segments of the 5¢-flanking
region linked to a luciferase gene indicated that a 537-bp
SalI/SacI fragment upstream of exon 1 was sufficient to
promote high level gene expression By 5¢-rapid
amplifica-tion of cDNA ends (5¢-RACE) using a cap site-labeled
cDNA library, we determined one major and one minor
transcription start sites in this region The murine a3 integrin
gene was found to contain a CCAAT box, but to lack a
TATA box Luciferase assay following transfection with a series of deletion constructs of the SalI/SacI fragment revealed that the sequence between positions )260 and )119 bp (relative to the major transcription start site) is required for efficient transcription in gastric carcinoma cells The sequence analysis of this segment showed the presence
of several consensus sequences for transcription factors including Ets, GATA and MyoD/E-box binding factors The introduction of mutation in one of the Ets-binding sequences greatly decreased its promoter activity, suggesting that the transcription of the a3 integrin gene in these cells is regulated by the Ets-family of transcription factors Keywords: integrin; gene promoter; luciferase assay; Ets-transcription factor; gastric carcinoma cell
The a3b1 integrin (VLA-3) is a transmembrane
glycopro-tein consisting of a noncovalently associated heterodimer
(a3 and b1 subunits), and serves as an adhesion receptor
that mediates both cell-extracellular matrix and cell–cell
interactions It has been suggested that this integrin is a
promiscuous receptor for a variety of extracellular matrix
proteins such as fibronectin, collagen, and laminin-1 (a
prototype of laminin), and for cell surface counter-ligands
[1–5] Several recent studies have demonstrated that the
a3b1 integrin functions as a high-affinity receptor for
isoforms of laminin, i.e laminin-5 and laminin-10/11 [6–
9] More recently, thrombospondin-1 has been reported to
be a ligand for a3b1 integrin [10] The a3 integrin-deficient
mice die at birth, with lung, kidney, and skin defects,
suggesting that this integrin plays a crucial role in their
development and differentiation [11] It has also been
reported that the a3b1 integrin forms complexes with
other cell-surface proteins, including transmembrane-4
superfamily (TM4SF, tetraspanin) proteins, and that these
complexes may play key roles in cell adhesion, motility,
signaling, transport, and other cell membrane functions [1] The cDNA for the hamster, human, and mouse integrin a3 subunit has been cloned [12–15] A variant of the integrin a3 subunit with a different cytoplasmic sequence has been detected [16], and its specific tissue distribution has been reported [17] We previously isolated mouse genomic clones encoding the integrin a3 subunit and found that the gene was encoded by 26 exons spanning over 40 kb [18] We have demonstrated that the splicing variants of the a3 subunits (a3A and a3B) are generated by an alternative exon usage
Our previous reports showed that the expression of the a3b1 integrin at both protein and mRNA levels is increased after the oncogenic transformation of fibroblasts by SV40
or polyoma virus [12,13] The enhanced expression of this integrin receptor on transformed cells is likely to be related
to their oncogenic phenotypes A number of studies have demonstrated the aberrant expression of a3b1 integrin in various tumor cells in association with changes in their invasive and metastatic potentials [19–27] In gastric carci-noma, melacarci-noma, and glioma, the expression of the a3b1 integrin in these cells was positively correlated with their malignancy [28–30] It has also been reported that a3b1 integrin expression is closely related to the cell invasion and metastatic potentials of gastric carcinoma cells [24] Thus, the regulatory mechanism for a3b1 integrin expression in these cancer cells seems to be of considerable interest In the present study, we characterized the promoter region of the mouse integrin a3 subunit gene, and present evidence showing that its expression is regulated by the Ets-family of transcription factors in carcinoma cells
Correspondence to T Tsuji, Department of Microbiology, Hoshi
University School of Pharmacy and Pharmaceutical Sciences,
2-4-41 Ebara, Shinagawa-ku, Tokyo 142–8501, Japan.
Fax: + 81 3 5498 5753, E-mail: tsuji@hoshi.ac.jp
Abbreviations: SV40, simian virus 40; EMSA, electrophoretic mobility
shift assay.
Note: nucleotide sequence data are available in the DDBJ/EMBL/
GenBank databases under the accession number AB080229
(Received 1 May 2002, revised 19 July 2002, accepted 26 July 2002)
Trang 2M A T E R I A L S A N D M E T H O D S
Reagents
Restriction endonucleases and modifying enzymes were
purchased from TaKaRa (Osaka, Japan), TOYOBO
(Osaka, Japan) and Gibco BRL (Rockville, MD, USA)
p-Nitrophenyl b-D-galactopyranoside was from Sigma (St
Louis, MO, USA) Luciferase Assay System and Tfx-20TM
were purchased from Promega Corp (Madison, WI, USA)
Oligonucleotides were synthesized by
Amersham-Pharma-cia Biotech (Tokyo, Japan)
Cells
Human gastric carcinoma cell lines, MKN1, MKN28 and
MKN45, were supplied by RIKEN Cell Bank (Tsukuba,
Japan) A human gastric carcinoma cell line, KATO III,
was supplied by Health Science Research Resources Bank
(Osaka, Japan) These cells were cultured in RPMI 1640
medium (Gibco BRL) supplemented with 10% fetal bovine
serum (HyClone, Logan, UT, USA) at 37C under 5%
CO2
Flow cytometric analysis
The expression of the a3 integrin was measured using a flow
cytometer (FACSCalibur, Becton-Dickinson, San Jose, CA,
USA) employing a monoclonal anti-human a3 integrin
antibody (SM-T1) and FITC-labeled anti-mouse IgG (ICN
Pharmaceuticals Inc., Costa Mesa, CA, USA) as described
previously [4]
Cloning of the 5¢-flanking region of mouse integrin a3
subunit gene
A mouse (BALB/c) genomic library constructed in
kEMBL3 was screened with the cDNA for the mouse
integrin a3 subunit as described previously [18] The
restriction fragments obtained by the digestions with
BamHI, EcoRI, and/or HindIII from positive clones were
subcloned into pBluescript SK(+) (Stratagene, La Jolla,
CA, USA), and analyzed by restriction enzyme mapping
and Southern hybridization using mouse integrin a3 subunit
cDNA From the results of these analyses, an EcoRI/
HindIII fragment (3aEH70) was found to contain the
5¢-flanking region and exon 1 of the mouse integrin a3 subunit
gene (Fig 1)
Construction of reporter plasmids
The 4.0 kb EcoRI/SacI fragment of clone 3aEH70 was
inserted into the luciferase gene-containing plasmid
pGL3-basic (Promega), which lacks eukaryotic promoter and
enhancer sequences A series of deletions was prepared by
use of restriction sites (PstI, XbaI, and SalI) (Fig 1) and by
the method using exonuclease III [31] (Deletion Kit,
TaKaRa, Osaka, Japan) To obtain additional deletion
constructs, PCR was performed by using Taq DNA
polymerase (TaKaRa Ex TaqTM), 3aEH70 plasmid as a
template, and the sets of primers listed in Table 1 After the
PCR products were digested with KpnI and SacI, the
fragments were inserted into the KpnI/SacI site of
pGL3-basic vector We confirmed by sequencing analysis that no mutation due to PCR had occurred
PCR-based site-directed mutagenesis was performed according to the method described by Weiner et al [32] The PCR was performed using pfu DNA polymerase (Stratagene) with K3S2 plasmid ()260/)119 in pGL-3 basic) as a template and a double-stranded oligonucleotide, which has a mutation at the consensus binding sequence for Ets ()248 or )133), MyoD/E-box binding factors ()241) or GATA ()212) (Table 1) The conditions for the PCR were
as follows: 95C, 1 min; 56 C, 1 min; 72 C, 6 min; 20 cycles The PCR products were sequentially treated with DpnI and with KpnI/SacI The digested fragment after electrophoretic separation on an agarose gel was subcloned into the KpnI/SacI site of pGL-3-basic plasmid The introduction of the mutation was confirmed by the nucleo-tide sequencing
DNA sequencing Nucleotide sequence was determined using a DNA sequencer (Applied Biosystems model 377, Foster City,
CA, USA) by means of the BigDyeTM terminator cycle sequencing method The primers used are as follows: M13
Fig 1 Structures of the 5¢-flanking region of mouse a3 integrin gene The map (upper line) shows the organization of exons 1–3 and the 5¢-flanking region with the positions for HindIII (H) and EcoRI (E) The restriction map for the 5¢-flanking region is also shown at a higher magnification (lower line) The translation initiation site is indicated by ATG.
Table 1 Oligodeoxynucleotide primers used in PCR experiments Mutated bases are underlined.
Primer Sequence
mEts-R* 5¢- GACACCTGTCGGTAACCCTTAAAGCC -3¢ mGATA* 5¢- CGGAGTCGCCTAAGGAGAGATGGAGA -3¢ mE-box* 5¢- AGGGTTCCCGATCGGTGTCTGAGAGA -3¢ mEts-F* 5¢- TTTTCTCTTTCCCCGTAAGGAAAGCA -3¢
Trang 3()21) universal primer for pBluescript SK(+); 5¢-CTT
TATGTTTTTGGCGTCTTCC-3¢ (GL primer) and
5¢-CTAGCAAAATAGGCTGTCCC-3¢ (RV primer) for
plasmids constructed in pGL3-basic
Transfection and luciferase assay
Luciferase assay was conducted using a Luciferase Assay
System (Promega) along with reporter plasmids constructed
in pGL3-basic plasmid Carcinoma cells (5· 105cells) were
seeded in a 35-mm dish and cultured for 20 h The cells were
then transfected with the mixture of the plasmid construct in
pGL3 vector (3.0 lg) and pRSV-b-Gal (1.0 lg) (used as an
internal control) using the lipofection method employing
Tfx-20TM(Promega) in serum-free media (ASF-104,
Ajino-moto, Tokyo, Japan) for 1 h, and subsequently cultured for
48 h in RPMI-1640/10% fetal bovine serum After the cells
were harvested, the cell extracts were assayed for luciferase
activity with a luminometer An aliquot of the cell extract
was assayed for b-galactosidase by using 2 mM
p-nitrophe-nyl b-D-galactoside as a substrate in 20 mM sodium
phosphate buffer (pH 7.5) in order to estimate the
trans-fection efficiency in each sample
Determination of transcription start sites
A modified method of 5¢-rapid amplification cDNA ends
(5¢-RACE) with a cap site-labeled cDNA library was
employed for the determination of transcription start sites
[33] The cap site-labeled cDNA library derived from
murine kidney was supplied by Nippon Gene Co., Ltd
(Toyama, Japan) The library was prepared by the cleavage
of the cap structures of mRNA with Tobacco acid
pyrophosphatase followed by ligation with a synthetic
oligoribonucleotide (5¢-GUUGCGUUACAAGGUACGC
CACAGCGUAUGAUGCGUAA-3¢) and the reverse
transcription with a Moloney murine leukemia virus reverse
transcriptase By using the cap site-labeled cDNA library as
a template, PCR was performed with a set of two primers;
5¢-CAAGGTACGCCACAGCGTATG-3¢ (1RC primer,
corresponding to a part of the sequence in the above
synthetic oligoribonucleotide) and 5¢- CGCTGCACCGGT
AGTCAGGCAAT-3¢ (antisense primer 1, complementary
to +217/+195 of the murine a3 integrin gene)
Subse-quently, nested PCR was carried out with 5¢-GTACGCCA
CAGCGTATGATGC-3¢ (2RC primer, corresponding to
an inner sequence of the synthetic oligoribonucleotide) and
5¢-CCGTTCCGAGCTCCGAGCAC-3¢ (antisense primer
2, complementary to +90/+71 of the murine a3 integrin
gene) The condition for the PCR was as follows: 95C,
20 s; 60C, 20 s; 72 C, 30 s; 30 cycles The products were
separated by 2.5% agarose gel electrophoresis in 40 mM
Tris/acetate buffer (pH 8.0) containing 1 mM EDTA
(1· Tris/acetate/EDTA), and subcloned into a pGEM-T
easy vector (Promega)
Electrophoretic mobility shift assay (EMSA)
Preparation of nuclear extracts from MKN1 cells and
EMSA were performed essentially as described by Ko et al
[34] The DNA fragments containing the putative
Ets-binding sequence of the 5¢-flanking region of the mouse a3
integrin gene were synthesized; 5¢-TTTTCTCTTTCCCCG
GAAGGAAAGCAGAG-3¢ (wild-type) and 5¢-TTTTCTC TTTCCCCGTAAGGAAAGCAGAG-3¢ (mutant) The double-stranded oligonucleotides were labeled with [c-32P]ATP (Amersham Biosciences) and T4 polynucleotide kinase (TaKaRa), and used as probes.32P-labeled probes (15 000 d.p.m.) and nuclear extracts (5 lg protein) were mixed in 0.02 mL of 25 mM Tris/HCl (pH 7.9), 65 mM
KCl, 6 mMMgCl2, 0.25 mM EDTA and 10% glycerol in the presence of 400 ng of dI-dC, and incubated for 30 min
at room temperature The mixture was then subjected to polyacrylamide gel (6%) electrophoresis using 10 mMTris/ acetate (pH 7.8) containing 0.25 mM EDTA (0.25· Tris/ acetate/EDTA) as running buffer
R E S U L T S
Structure and transient expression analysis of the 5¢-flanking region of mouse integrin a3 subunit gene
We previously cloned the 5¢-flanking region of the integrin a3 subunit gene from a mouse genomic library [18] The restriction map for this region is shown in Fig 1 The clone contains exon 1 and approximately 4.0 kb of the 5¢-flanking region of exon 1 of the mouse integrin a3 subunit gene We prepared a chimeric construct (pGL-ES), in which the 4.0 kb EcoRI/SacI fragment upstream of exon 1 was inserted into the luciferase gene-containing plasmid pGL3-basic in order to examine its promoter activity Luciferase expression was measured following the transfection of
pGL-ES into four human gastric carcinoma cell lines, which differently express the a3 integrin subunit When the construct was introduced into these cell lines, it promoted higher levels of luciferase activity than the background levels
in all cell lines tested (Table 2) The relative luciferase activity induced by the transfection in each cell line roughly parallels the level of a3 integrin expression as measured by flow cytometry (Fig 2), suggesting that this region includes elements that up-regulate the expression of the integrin a3 subunit gene in gastric carcinoma cells
To specify the region of the 5¢-flanking segment essential for the promoter activity, we prepared serially deleted constructs and analyzed the transient expression of luci-ferase activity after transfection into MKN1 cells, which were established from gastric cancer metastasis [35] (Fig 3) L2.5 and L2.3 induced similar levels of luciferase activity to the original pGL-ES (L4.0) in these cells, and further deleted
Table 2 Transient expression analysis of integrin a3 subunit gene pro-moter activity in gastric carcinoma cell lines.
Host cell line
a3 integrin expressiona
Relative luciferase activityb
a
The expression of the integrin a3 was measured by flow cyto-metric analysis using a monoclonal anti-integrin a3 antibody (Fig 2) b Values (mean ± SD) are normalized to b-galactosidase activity and expressed in relation to the activity of pGL3-basic taken as 1.0 Triplicate transfections were performed in each experiment.
Trang 4constructs (L1.8, L1.5 and L1.3) showed higher levels of
luciferase activity than did L4.0 Among the deletion
constructs tested, L1.2 had the highest relative luciferase
activity L0.5 also showed a comparable high activity These
results indicate that strong promoter activity is located
within the 0.5 kb stretch of the sequence between the SalI
and SacI sites upstream of exon 1, and that putative
suppressor elements are present between the PstI
(approxi-mately 2.5 kb upstream of the SacI site) and XbaI
(approximately 1.2 kb upstream of the SacI) sites (Fig 1)
Sequence analysis of the 5¢-flanking region and determination of transcription start sites of mouse integrin a3 subunit gene
The nucleotide sequence of the 0.5 kb SalI/SacI fragment and a part of exon 1 is shown in Fig 4 A TRANSFACTM
(GBF-AGBIN, Braunschweig, Germany) database search
of this sequence revealed the presence of a number of potential regulatory elements, including consensus binding sequences for GATA, NF-jB/Rel, Sp1, Ets, and MyoD/ E-box binding transcription factors No canonical TATA box but a CCAAT box was found in the mouse integrin a3 subunit flanking sequence The integrin a subunit genes so far characterized contain no CCAAT box except for human integrin a4 subunit gene, which includes a GCAAT sequence in its promoter region The presence of a CCAAT box seems to be a characteristic feature of the a3 integrin gene among integrin a subunit genes
Fig 2 Flow cytometric analysis of the expression of the integrin a3
subunit in gastric carcinoma cells Profiles of control experiments
without anti-integrin a3 subunit antibody are also shown by thin lines.
(A) KATO III; (B) MKN28; (C) MKN45; (D) MKN1.
Fig 3 Promoter activity of serial deletion constructs of the 5¢-flanking
region of the mouse integrin a3 subunit gene Relative luciferase activity
was determined following the introduction of various deletion
con-structs derived from pGL-ES (L4.0, a construct with the 4.0 kb EcoRI/
SacI fragment) into MKN1 gastric carcinoma cells The activity was
normalized to b-galactosidase activity induced by cotransfection with
pRSV-b-Gal plasmid The assays were carried out in triplicate, and the
error bars indicate the standard deviation.
Fig 4 Nucleotide sequence of the 5¢-flanking region of the mouse a3 integrin gene Major and minor transcription start sites determined by the cap site-labeled method are marked by closed and open triangles, respectively Bases are numbered with respect to the major starting site Potential binding sites for transcription factors are underlined and a consensus sequence for C/EBP (CCAAT) is boxed The translation start site (ATG) and the cleavage site in the processing of the poly-peptide (arrow) are also shown The nucleotide sequence of the 5¢-flanking region and exon 1 has been deposited in DDBJ/EMBL/ GenBank (accession number AB080229).
Trang 5To determine the transcription start sites for the integrin
a3 subunit gene, a modified method of 5¢-RACE using a cap
site-labeled cDNA library was employed, recently
devel-oped for rapid examination of 5¢-end of genes [33] After the
amplification by PCR, the products were separated on 2.5%
agarose gel electrophoresis (Fig 5) Three bands were
observed when the PCR reaction was performed in the
presence of the cap site-labeled cDNA library (Fig 5, lane
1), whereas the PCR reaction mixture in the absence of the
cDNA library gave one band corresponding to that with
the highest mobility (Fig 5, lane 2) Thus, we conclude that
the most prominent band with the highest mobility
repre-sents primers used for PCR The other two bands, which
seem to be derived from the 5¢-cap site-labeled cDNA for
the integrin a3 subunit gene, were separately excised and
DNA fragments were extracted Subcloning the fragments
into pGEM-T easy vector followed by sequence analysis
revealed that major and minor transcription start sites are
332 bp and 276 bp, respectively, upstream of the translation
initiation ATG We hereafter refer to the major
transcrip-tion initiatranscrip-tion C residue as +1 (indicated by the closed
triangle in Fig 4)
The two transcription start sites were surrounded by
GC-rich sequences including the binding sites for transcription
factor Sp1, as frequently found in promoters without a
TATA box Transcription from so-called TATA-less gene
promoters initiates at a consensus sequence designated as
the initiator sequence [36] The sequences surrounding the
two transcription start sites of the mouse integrin a3 subunit
gene resembled the pyrimidine-rich initiator consensus
sequence, as found in most integrin a subunit genes lacking
a TATA box (Fig 6) It should be noted that a consensus
CCT sequence was found at 3–8 bases downstream of the
transcription start sites for integrin a3, a5, a7, aL, aM, aX, and aIIb subunit genes, all of which lack a TATA box in their promoter regions [37–48]; i.e the consensus sequence can be represented by Py2A/CN2)7CCT
Promoter activity of deletions and mutations derived from the 5¢-flanking segment
We next prepared a series of deletion constructs and analyzed their promoter activity in MKN1 cells The L0.5 construct which includes the SalI/SacI fragment upstream
of the a3 integrin gene with high promoter activity (Fig 3) was deleted stepwisely from its 5¢-end As shown in Fig 7A, L0.5, L0.4 and L0.3 were almost equally active as a promoter in these cells However, the promoter activity of L0.2 was greatly diminished and that of L0.1 was almost completely abolished when compared with L0.3 This result indicates that segments essential for regulating the expres-sion of the integrin a3 subunit gene are present between )260 and )134 To confirm that this region is responsible for the regulation of a3 integrin expression, we subsequently prepared several constructs with or without this segment by PCR and successive subcloning into pGL3-basic vector The transfection experiments using MKN1 cells demon-strated that the constructs including the)260/)119 region (L0.4, K4S1, K4S2, K3S1 and K3S2) showed high luci-ferase activity, but those without this region (K4S3 and K2S1) did not (Fig 7B) These results indicate that the elements located between)260 and )119 promote efficient transcription
As several consensus binding sequences for known transcription factors such as GATA, Ets, and MyoD/ E-box binding factors were present within)260/)119, we
Fig 5 Agarose gel electrophoresis of the PCR products of a cap site
region of the mouse a3 integrin mRNA PCR was carried out using a
cap site-labeled cDNA library as a template and primers as described
in Materials and methods The products were separated in 2.5%
agarose gel in 40 m M Tris/acetate buffer containing 1 m M EDTA
(pH 8.0) Lane 1, PCR products in the presence of a cDNA library
derived from mouse kidney mRNA; lane 2, PCR products in the
absence of the cDNA library.
Fig 6 Transcription start sites in the integrin a subunit genes The sequences flanking the transcription start sites in the integrin a subunit genes are shown; chicken a1 [37], human a2 [38], human a4 [39], human a5 [40], human a6 [41,42], murine a7 [43], human aL [44], human aM [45,46], human aX [47], and human aIIb [48] A consensus CCT sequence present in most of the integrin a subunit genes that lack
a TATA box is underlined The transcription start site (+1 position) is indicated by a triangle *GCAAT; **GATAAA.
Trang 6attempted to introduce mutations into these sequences As
shown in Fig 8, the introduction of mutation into one of
the Ets-binding sequences at )133 (GGAA to GTAA)
greatly decreased the promoter activity, whereas mutations
in the other Ets-binding site at)248 (TTCC to TTAC), the
E-box at)241 (CAGGTG to TCGGTG), or the
GATA-binding site at )212 (GATA to CTAA) showed no
substantial effect
Electrophoretic mobility shift assay (EMSA) using
the Ets consensus site at)133
As the involvement of the Ets consensus binding site at)133
in the promoter activity of the mouse a3 integrin gene was
suggested by the luciferase assay, this region was further
studied using EMSA An oligonucleotide corresponding to
the a3 integrin promoter region ()147 to )119) and
containing the wild-type or mutant Ets-binding site was
used as a probe to detect binding activity in MKN1 cells
The mutant oligonucleotide differs from the wild-type by
single base substitution at the Ets consensus core sequence
as shown in Materials and methods In the mobility shift
assay, we detected one band with the wild-type
oligonucleo-tide, but it was absent when the mutant oligonucleotide was
used as a probe (Fig 9) The binding activity appeared to be specific for the Ets consensus site as the binding competed with the excess unlabeled wild-type, but not with the mutant oligonucleotide
D I S C U S S I O N
The a3b1 integrin has been thought to play crucial roles in various physiological and pathological processes including cellular proliferation, differentiation, development, wound healing, angiogenesis, transformation, and apoptosis [1] A vital role of the a3b1 integrin in organogenesis has been suggested, as mice deficient in this integrin receptor die during the neonatal period with kidney and lung defects and skin blistering [11] Additional abnormalities in the mor-phogenesis of limbs were observed in integrin a3/a6-deficient mice; e.g the absence of digit separation and the fusion of preskeletal elements [49] These observations suggest that the a3b1 integrin plays essential roles in multiple processes during embryogenesis The promoter should thus contain elements directing the expression of this integrin in the kidney, lung, and skin A number of studies
Fig 7 Promoter activity of serial deletion constructs of the 5¢-flanking
region of the mouse integrin a3 subunit gene Relative luciferase activity
was determined following the introduction of various deletion
con-structs derived from L0.5 (a construct with the 0.5 kb SalI/SacI
fragment) into MKN1 cells The activity was normalized to
b-galac-tosidase activity induced by co-transfection with pRSV-b-Gal plasmid.
The assays were carried out in triplicate, and the error bars indicate the
standard deviation.
Fig 8 Effects of mutations in the Ets- and GATA-binding sites and the E-boxof the mouse a3 integrin gene on promoter activity MKN1 cells were transfected with wild type (K3S2) or mutated constructs Relative luciferase activity was determined in triplicate, and data were nor-malized to b-galactosidase activity.
Fig 9 Electrophoretic mobility shift assay using probes containing a putative Ets binding site at –133 A32P-labeled oligonucleotide probe (W, wild-type; M, mutant) was incubated with nuclear extracts from MKN1 cells For competition analysis, 20-fold molar excess of the unlabeled oligonucleotide (W, wild-type; M, mutant) was added before the incubation.
Trang 7also demonstrated the relationship between the aberrant
expression of a3b1 integrin in tumor cells and their
malignant behavior The increased expression of a3b1
integrin in gastric carcinoma cells is associated with their
increased invasion and metastatic potentials [24,28] Thus,
the transcriptional regulation for the integrin a3 subunit is
one of crucial issues to be resolved in cancer biology We
previously reported the structures of the mouse a3 integrin
subunit gene including the exon/intron organization and the
alternative exon usage for the generation of variants of the
a3 subunits (a3A and a3B) [18] In the present study, we
characterized the promoter region for this integrin receptor
Most integrin a subunit genes lack both TATA and
CCAAT boxes, except for the integrin a4 subunit gene
which includes both TATA and CCAAT boxes and for the
integrin a6 subunit gene which contains a TATA-like box
but lacks a CCAAT box (Fig 6) By contrast, the promoter
for the mouse integrin a3 gene was found to lack a TATA
box, but does contain a CCAAT box at 324 bp upstream of
the major transcription start site The presence of a CCAAT
box and the absence of a TATA box seem to be one of the
characteristics of the mouse integrin a3 gene
We identified two transcription start sites using a
modified method of 5¢-RACE employing a cap site-labeled
cDNA library The sequences around these transcription
start sites of the mouse integrin a3 subunit gene showed
considerable homology to those of known integrin a
subunit genes (Fig 6) Most integrin a subunit genes
without a TATA box (a3, a5, a7, aL, aM, aX and aIIb
subunit genes) contain a consensus Py2A/CN2)7CCT
sequence (where A/C is the transcription start site) The
role of the sequence containing CCT is unknown but it
might play a role in the initiation of transcription
The active promoter region of the mouse integrin a3 gene
in MKN1 cells was mapped in)260/)119 The sequence
analysis of this region revealed the presence of consensus
binding sequences for several transcription factors including
Ets, GATA, and MyoD/E-box binding factors The
introduction of mutation into one of the putative
Ets-binding sequences suppressed the promoter activity In
addition, the specific binding of a nuclear protein to the
oligonucleotide containing the Ets consensus sequence was
detected in EMSA These results suggest that the
transcrip-tion of the mouse integrin a3 subunit gene is regulated by
the Ets-family transcription factors in these cells A
homology search between human and mouse a3 integrin
genes revealed that the Ets consensus core sequence and its
flanking sequences were well conserved and present at
approximately 460 bp upstream of the translation initiation
ATG in the human a3 integrin gene (DDBJ/EMBL/
GenBank database; accession number AC002401)
How-ever, it remains to be identified which transcription factor of
the Ets-family is involved in the regulation The members of
the Ets-family of transcription factors bind to specific
purine-rich sequences with a core motif of GGAA/T and
control the expression of numerous genes that are critical
for various biological processes including cellular
prolifer-ation, differentiprolifer-ation, development, transformprolifer-ation, and
apoptosis [50]
It has been reported that Ets transcription factors were
involved in tumor metastasis through angiogenesis and the
expression of metalloproteinases or collagenases [51–53] It
was recently reported that these transcription factors
regulated the expression of the aV integrin in mouse melanoma cells [54] and the a5 integrin in human glioma cells [55] These factors have also been shown to regulate the expression of N-acetylglucosaminyltransferase V [34,56] and a(1,3) fucosyltransferase IV [57] The former enzyme is responsible for the synthesis of the b1–6 branch in N-acetyllactosamine units in cell surface N-glycans, and the latter enzyme is involved in the synthesis of cell surface ligands for E-selectin; both carbohydrate structures have been reported to be associated with cellular metastatic potential The invasion and metastasis of cancer cells are thought to include complicated processes Extracellular matrix-degrading enzymes are crucial for cell invasion and angiogenesis Cell adhesion molecules and carbohydrate chains present on cell membranes also define the cell– substratum interaction in the initial attachment of cancer cells to target tissues in the metastatic process The overexpression of a3b1 integrin as well as matrix metallo-proteinases and collagenases may cooperatively potentiate cellular metastatic activity
A C K N O W L E D G E M E N T S
We thank Dr Kensuke Suzuki (Pharmaceutical Frontier Research Laboratories, Japan Tobacco Inc.) for his helpful discussion We are also grateful Ms Nami Kawai and Ms Yoko Kawame for their technical assistance This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
R E F E R E N C E S
1 Kreidberg, J.A (2000) Functions of a3b1 integrin Curr Opin Cell Biol 12, 548–553.
2 Symington, B.E., Takada, Y & Carter, W.G (1993) Interaction of integrins a3b1 and a2b1: potential role in keratinocyte intercel-lular adhesion J Cell Biol 120, 523–535.
3 Sriramarao, P., Steffner, P & Gehlsen, K.R (1993) Biochemical evidence for a homophilic interaction of the a3b1 integrin J Biol Chem 268, 22036–22041.
4 Takeuchi, K., Tsuji, T., Hakomori, S & Irimura, T (1994) Intercellular adhesion induced by a3 integrin (VLA-3) anti-bodies Exp Cell Res 211, 133–141.
5 Weitzman, J.B., Chen, A & Hemler, M.E (1995) Investigation of the role of b1 integrins in cell–cell adhesion J Cell Sci 108, 3635– 3644.
6 Carter, W.G., Ryan, M.C & Gahr, P.J (1991) Epiligrin, a new cell adhesion ligand for integrin a3b1 in epithelial basement mem-branes Cell 65, 599–610.
7 Marinkovitch, M.P., Verrando, P., Keene, D.R., Meneguzzi, G., Lunstrum, G.P., Ortonne, J.P & Burgeson, R.E (1993) Basement membrane proteins kalinin and nicein are structurally and immunologically identical Laboratory Invest 69, 295–299.
8 Kikkawa, Y., Umeda, M & Miyazaki, K (1994) Marked stimu-lation of cell adhesion and motility by ladsin, a laminin-like scatter factor J Biochem (Tokyo) 116, 862–869.
9 Kikkawa, Y., Sanzen, N & Sekiguchi, K (1998) Isolation and characterization of laminin-10/11 secreted by human lung carci-noma cells laminin-10/11 mediates cell adhesion through integrin a3b1 J Biol Chem 273, 15854–15859.
10 Guo, N., Templeton, N.S., Al-Barazi, H., Cashel, J.A., Sipes, J.M., Krutzsch, H.C & Roberts, D.D (2000) Thrombospondin-1 promotes a3b1 integrin-mediated adhesion and neurite-like out-growth and inhibits proliferation of small cell lung carcinoma cells Cancer Res 60, 457–466.
Trang 811 Kreidberg, J.A., Donovan, M.J., Goldstein, S.L., Rennke, H.,
Shepherd, K., Jones, R.C & Jaenisch, R (1996) a3b1 integrin has
a crucial role in kidney and lung organogenesis Development 122,
3537–3547.
12 Tsuji, T., Yamamoto, F., Miura, Y., Takio, K., Titani, K., Pawar,
S., Osawa, T & Hakomori, S (1990) Characterization through
cDNA cloning of galactoprotein b3 (Gap b3), a cell surface
membrane glycoprotein showing enhanced expression on
onco-genic transformation Identification of Gap b3 as a member of the
integrin superfamily J Biol Chem 265, 7016–7021.
13 Tsuji, T., Hakomori, S & Osawa, T (1991) Identification of
hu-man galactoprotein b3, an oncogenic transformation-induced
membrane glycoprotein, as VLA-3 a subunit: the primary
struc-ture of human integrin a3 J Biochem (Tokyo) 109, 659–665.
14 Takada, Y., Murphy, E., Pil, P., Chen, C., Ginsberg, M.H &
Hemler, M.E (1991) Molecular cloning and expression of the
cDNA for a3 subunit of human a3b1 (VLA-3), an integrin
receptor for fibronectin, laminin, and collagen J Cell Biol 115,
257–266.
15 Takeuchi, K., Hirano, K., Tsuji, T., Osawa, T & Irimura, T.
(1995) cDNA cloning of mouse VLA3 a subunit J Cell Biochem.
57, 371–377.
16 Tamura, R.N., Cooper, H.M., Collo, G & Quaranta, V (1991)
Cell type-specific integrin variants with alternative a chain
cyto-plasmic domains Proc Natl Acad Sci USA 88, 10183–10187.
17 de Melker, A.A., Sterk, L.M., Delwel, G.O., Fles, D.L., Daams,
H., Weening, J.J & Sonnenberg, A (1997) The A and B variants
of the a3 integrin subunit: tissue distribution and functional
characterization Laboratory Invest 76, 547–563.
18 Tsuji, T., Han, S.A., Takeuchi, K., Takahashi, N., Hakomori, S.
& Irimura, T (1999) Characterization of mouse integrin a3
sub-unit gene J Biochem (Tokyo) 125, 1183–1188.
19 Dedhar, S., Saulnier, R., Nagle, R & Overall, C.M (1993) Specific
alterations in the expression of a3b1 and a6b4 integrins in highly
invasive and metastatic variants of human prostate carcinoma
cells selected by in vitro invasion through reconstituted basement
membrane Clin Exp Metastasis 11, 391–400.
20 Bartolazzi, A., Cerboni, C., Flamini, G., Bigotti, A., Lauriola, L.
& Natali, P.G (1995) Expression of a3b1 integrin receptor and its
ligands in human lung tumors Int J Cancer 64, 248–252.
21 Melchiori, A., Mortarini, R., Carlone, S., Marchisio, P.C.,
Anichini, A., Noonan, D.M & Albini, A (1995) The a3b1
inte-grin is involved in melanoma cell migration and invasion Exp.
Cell Res 219, 233–242.
22 Bartolazzi, A., Cerboni, C., Nicotra, M.R., Mottolese, M., Bigotti,
A & Natali, P.G (1994) Transformation and tumor progression
are frequently associated with expression of the a3/b1 heterodimer
in solid tumors Int J Cancer 58, 488–491.
23 Van Waes, C., Surh, D.M., Chen, Z., Kirby, M., Rhim, J.S.,
Brager, R., Sessions, R.B., Poore, J., Wolf, G.T & Carey, T.E.
(1995) Increase in suprabasilar integrin adhesion molecule
expression in human epidermal neoplasms accompanies increased
proliferation occurring with immortalization and tumor
progres-sion Cancer Res 55, 5434–5444.
24 N ishimura, S., Chung, Y.S., Yashiro, M., Inoue, T & Sowa, M.
(1996) Role of a2b1- and a3b1-integrin in the peritoneal
implan-tation of scirrhous gastric carcinoma Br J Cancer 74, 1406–1412.
25 Tawil, N.J., Gowri, V., Djoneidi, M., Nip, J., Carbonetto, S &
Brodt, P (1996) Integrin alpha3beta1 can promote adhesion and
spreading of metastatic breast carcinoma cells on the lymph node
stroma Int J Cancer 66, 703–710.
26 Lichtner, R.B., Howlett, A.R., Lerch, M., Xuan, J.A., Brink, J.,
Langton-Webster, B & Schneider, M.R (1998) Negative
cooperativity between a3b1 and a2b1 integrins in human
mam-mary carcinoma MDA MB 231 cells Exp Cell Res 240, 368–376.
27 Adachi, M., Taki, T., Huang, C., Higashiyama, M., Doi, O., Tsuji,
T & Miyake, M (1998) Reduced integrin a3 expression as a factor
of poor prognosis of patients with adenocarcinoma of the lung.
J Clin Oncol 16, 1060–1067.
28 Ura, H., Denno, R., Hirata, K., Yamaguchi, K & Yasoshima, T (1998) Separate functions of a2b1 and a3b1 integrins in the meta-static process of human gastric carcinoma Surg Today 28, 1001– 1006.
29 Schumacher, D & Schaumburg-Lever, G (1999) Ultrastructural localization of alpha-3 integrin subunit in malignant melanoma and adjacent epidermis J Cutan Pathol 26, 321–326.
30 Kishima, H., Shimizu, K., Tamura, K., Miyao, Y., Mabuchi, E., Tominaga, E., Matsuzaki, J & Hayakawa, T (1999) Monoclonal antibody ONS-M21 recognizes integrin a3 in gliomas and med-ulloblastomas Br J Cancer 79, 333–339.
31 Henikoff, S (1984) Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing Gene 28, 351– 359.
32 Weiner, M.P., Costa, G.L., Schoettlin, W., Cline, J., Mathur, E & Bauer, J.C (1994) Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction Gene 151, 119–123.
33 Maruyama, K & Sugano, S (1994) Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides Gene 138, 171–174.
34 Ko, J.H., Miyoshi, E., Noda, K., Ekuni, A., Kang, R., Ikeda, Y & Taniguchi, N (1999) Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines J Biol Chem 274, 22941–22948.
35 Yamada, Y., Yoshida, T., Hayashi, K., Sekiya, T., Yokota, J., Hirohashi, S., Nakatani, K., Nakano, H., Sugimura, T & Terada,
M (1991) p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases Cancer Res 51, 5800–5805.
36 Smale, S.T & Baltimore, D (1989) The ÔinitiatorÕ as a transcrip-tion control element Cell 57, 103–113.
37 Obata, H., Hayashi, K., Nishida, W., Momiyama, T., Uchida, A., Ochi, T & Sobue, K (1997) Smooth muscle cell phenotype-dependent transcriptional regulation of the a1 integrin gene.
J Biol Chem 272, 26643–26651.
38 Zutter, M.M., Santoro, S.A., Painter, A.S., Tsung, Y.L & Gafford, A (1994) The human a2 integrin gene promoter Iden-tification of positive and negative regulatory elements important for cell-type and developmentally restricted gene expression.
J Biol Chem 269, 463–469.
39 Rosen, G.D., Birkenmeier, T.M & Dean, D.C (1991) Char-acterization of the a4 integrin gene promoter Proc Natl Acad Sci USA 88, 4094–4098.
40 Birkenmeier, T.M., McQuillan, J.J., Boedeker, E.D., Argraves, W.S., Ruoslahti, E & Dean, D.C (1991) The a5b1 fibronectin receptor Characterization of the a5 gene promoter J Biol Chem.
266, 20544–20549.
41 Nishida, K., Kitazawa, R., Mizuno, K., Maeda, S & Kitazawa, S (1997) Identification of regulatory elements of human a6 integrin subunit gene Biochem Biophys Res Commun 241, 258–263.
42 Lin, C.S., Chen, Y., Huynh, T & Kramer, R (1997) Identification
of the human a6 integrin gene promoter DNA Cell Biol 16, 929– 937.
43 Ziober, B.L & Kramer, R.H (1996) Identification and char-acterization of the cell type-specific and developmentally regulated a7 integrin gene promoter J Biol Chem 271, 22915–22922.
44 Nueda, A., Lopez-Cabrera, M., Vara, A & Corbi, A.L (1993) Characterization of the CD11a (aL, LFA-1 a) integrin gene pro-moter J Biol Chem 268, 19305–19311.
45 Hickstein, D.D., Baker, D.M., Gollahon, K.A & Back, A.L (1992) Identification of the promoter of the myelomonocytic leu-kocyte integrin CD11b Proc Natl Acad Sci USA 89, 2105–2109.
46 Shelley, C.S & Arnaout, M.A (1991) The promoter of the CD11b gene directs myeloid-specific and developmentally regulated expression Proc Natl Acad Sci USA 88, 10525–10529.
Trang 947 Lopez-Cabrera, M., Nueda, A., Vara, A., Garcia-Aguilar, J.,
Tugores, A & Corbi, A.L (1993) Characterization of the
p150,95 leukocyte integrin alpha subunit (CD11c) gene promoter.
Identification of cis-acting elements J Biol Chem 268, 1187–
1193.
48 Prandini, M.H., Denarier, E., Frachet, P., Uzan, G & Marguerie,
G (1988) Isolation of the human platelet glycoprotein IIb gene
and characterization of the 5¢ flanking region Biochem Biophys.
Res Commun 156, 595–601.
49 De Arcangelis, A., Mark, M., Kreidberg, J., Sorokin, L &
Georges-Labouesse, E (1999) Synergistic activities of a3 and a6
integrins are required during apical ectodermal ridge formation
and organogenesis in the mouse Development 126, 3957–3968.
50 Sementchenko, V.I & Watson, D.K (2000) Ets target genes: past,
present and future Oncogene 19, 6533–6548.
51 Kaya, M., Yoshida, K., Higashino, F., Mitaka, T., Ishii, S &
Fujinaga, K (1996) A single ets-related transcription factor,
E1AF, confers invasive phenotype on human cancer cells
Onco-gene 12, 221–227.
52 Habelhah H., Okada, F., Kobayashi, M., Nakai, K., Choi, S.,
Hamada, J., Moriuchi, T., Kaya, M., Yoshida, K., Fujinaga, K &
Hosokawa, M (1999) Increased E1AF expression in mouse
fibrosarcoma promotes metastasis through induction of MT1-MMP expression Oncogene 18, 1771–1776.
53 Gutman, A & Wasylyk, B (1990) The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites EMBO J 9, 2241–2246.
54 Tajima, A., Miyamoto, Y., Kadowaki, H & Hayashi, M (2000) Mouse integrin av promoter is regulated by transcriptional factors Ets and Sp1 in melanoma cells Biochim Biophys Acta 1492, 377– 384.
55 Kita, D., Takino, T., Nakada, M., Takahashi, T., Yamashita, J & Sato, H (2001) Expression of dominant-negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin a5 expression in U251 glioma cell line Cancer Res 61, 7985–7991.
56 Kang, R., Saito, H., Ihara, Y., Miyoshi, E., Koyama, N., Sheng,
Y & Taniguchi, N (1996) Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct car-cinoma cells (HuCC-T1) is mediated by Ets-1 J Biol Chem 271, 26706–26712.
57 Withers, D.A & Hakomori, S (2000) Human a (1,3)-fucosyl-transferase IV (FUTIV) gene expression is regulated by elk-1 in the U937 cell line J Biol Chem 275, 40588–40593.